Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
New Report from MGA Examines the One-Year Cost Savings Lost Due to Patent Thickets

New Report from MGA Examines the One-Year Cost Savings Lost Due to Patent Thickets

Jan 26, 2023 | Analysis

New Report from MGA Examines the One-Year Cost Savings Lost Due to Patent Thickets MGA has released a new report today for the Coalition for Affordable Prescription Drugs (CAPD), “Patent Thickets and Lost Drug Savings.” This report, authored by Alex Brill...
New MGA Analysis of Biosimilar Coverage in Commercial Medical Benefit

New MGA Analysis of Biosimilar Coverage in Commercial Medical Benefit

Dec 8, 2022 | Analysis

New MGA Analysis of Biosimilar Coverage in Commercial Medical Benefit A new MGA white paper from CEO Alex Brill and Principal Christy Robinson shows a positive outlook for biosimilar coverage in the commercial medical benefit. While patients and physicians play a role...
Updated MGA Report Presents Biosimilar Market Opportunities in Ophthalmology

Updated MGA Report Presents Biosimilar Market Opportunities in Ophthalmology

Jul 14, 2022 | Analysis

Updated MGA Report Presents Biosimilar Market Opportunities in Ophthalmology MGA releases an updated report, “Biosimilar Market Opportunities in Ophthalmology.”  Authored by founder and CEO Alex Brill, the report examines the economics of biologic drugs for...
MGA Releases Economic Impact Report for Multinational Pharmaceutical Company

MGA Releases Economic Impact Report for Multinational Pharmaceutical Company

Jun 15, 2022 | Analysis

MGA Releases Economic Impact Report for Multinational Pharmaceutical Company In a newly released report, MGA highlights the broad economic impact of Otsuka Pharmaceutical in the U.S. operations. A leader in mental health and nephrology treatments, Otsuka offers both...
Updated MGA Report Presents Biosimilar Market Opportunities in Ophthalmology

New MGA Report Presents Biosimilar Market Opportunities in Ophthalmology

May 26, 2022 | Analysis

New MGA Report Presents Biosimilar Market Opportunities in Ophthalmology MGA releases a new report, “Biosimilar Market Opportunities in Ophthalmology.” Authored by founder and CEO Alex Brill, the report examines current trends and economics in the ophthalmology...
Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded

Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded

May 12, 2022 | Analysis

Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded MGA’s Alex Brill submitted a letter in response to a request for information from the Federal Trade Commission. The FTC was looking for information regarding the business practices of pharmacy benefit...
Page 1 of 712345...»Last »
  • Analysis (37)
  • Books (3)
  • Events (15)
  • Interviews (46)
  • News (51)
  • Op-Eds (79)
  • Press Releases (3)
  • Testimony (20)
  • Humira rivals drive down cost
    Humira Rivals Set to Try to Drive Down Cost of Blockbuster DrugJanuary 31, 2023
  • patent thickets lost drug savings
    New Report from MGA Examines the One-Year Cost Savings Lost Due to Patent ThicketsJanuary 26, 2023
  • Biosimilar Coverage in Commercial
    New MGA Analysis of Biosimilar Coverage in Commercial Medical BenefitDecember 8, 2022
  • Narrow House GOP Victory
    Narrow House GOP Victory Should Point Toward Policy Development AgendaDecember 6, 2022
  • Pandemic Fatigue Inhibit Pandemic Preparedness
    Don’t Let Pandemic Fatigue Inhibit Pandemic PreparednessNovember 15, 2022
  • Pro-Growth Tax System.
    American Renewal: A Simpler, More Responsible, and Pro-Growth Tax SystemNovember 15, 2022
  • Macroeconomics of the Child Tax Credit
    Macroeconomics of the Child Tax CreditNovember 10, 2022
  • 2022 Midterms and federal taxes
    2022 Midterms: How a Democratic or GOP Congress May Impact Your Federal TaxesOctober 26, 2022
  • Importance of Prescription Drug Rebates
    ‘The Price of Business’: Discussing State Taxation of Student Loan ForgivenessOctober 12, 2022
  • Massachusetts Millionaire’s Tax
    More Concerns with the Massachusetts Millionaire’s TaxOctober 11, 2022
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact